Gabelli Funds LLC Buys 4,755 Shares of Intuitive Surgical, Inc. $ISRG

Gabelli Funds LLC lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 70,480 shares of the medical equipment provider’s stock after buying an additional 4,755 shares during the quarter. Gabelli Funds LLC’s holdings in Intuitive Surgical were worth $31,521,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. Gamco Investors INC. ET AL grew its stake in Intuitive Surgical by 1.5% during the third quarter. Gamco Investors INC. ET AL now owns 10,595 shares of the medical equipment provider’s stock valued at $4,738,000 after acquiring an additional 152 shares in the last quarter. Aptus Capital Advisors LLC increased its holdings in Intuitive Surgical by 8.7% during the 3rd quarter. Aptus Capital Advisors LLC now owns 58,028 shares of the medical equipment provider’s stock worth $25,952,000 after acquiring an additional 4,649 shares during the period. Integrity Advisory Solutions LLC purchased a new stake in Intuitive Surgical in the 3rd quarter worth approximately $369,000. One Wealth Capital Management LLC lifted its stake in Intuitive Surgical by 13.3% in the 3rd quarter. One Wealth Capital Management LLC now owns 589 shares of the medical equipment provider’s stock worth $263,000 after purchasing an additional 69 shares in the last quarter. Finally, United Capital Management of KS Inc. boosted its holdings in Intuitive Surgical by 4.5% in the 3rd quarter. United Capital Management of KS Inc. now owns 12,296 shares of the medical equipment provider’s stock valued at $5,499,000 after purchasing an additional 534 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Mark Brosius sold 648 shares of the stock in a transaction dated Thursday, March 5th. The stock was sold at an average price of $495.20, for a total transaction of $320,889.60. Following the transaction, the senior vice president directly owned 2,906 shares in the company, valued at approximately $1,439,051.20. This represents a 18.23% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Fredrik Widman sold 133 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $65,829.68. Following the transaction, the vice president directly owned 660 shares in the company, valued at approximately $326,673.60. This represents a 16.77% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 37,261 shares of company stock valued at $19,690,721. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $490.16 on Friday. The firm’s fifty day moving average price is $521.64 and its 200-day moving average price is $512.05. The stock has a market cap of $174.07 billion, a P/E ratio of 62.12, a price-to-earnings-growth ratio of 3.83 and a beta of 1.66. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. During the same period in the previous year, the firm posted $2.21 EPS. The firm’s revenue was up 18.8% compared to the same quarter last year. On average, analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Ratings Changes

A number of research analysts have recently commented on the stock. Evercore reduced their price target on shares of Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating for the company in a research report on Friday, January 23rd. HSBC increased their price objective on Intuitive Surgical from $644.00 to $653.00 and gave the stock a “buy” rating in a research report on Monday, January 26th. Citigroup restated a “neutral” rating and set a $590.00 target price (down from $635.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Royal Bank Of Canada upped their target price on Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 17th. Finally, TD Cowen raised Intuitive Surgical to a “strong-buy” rating in a report on Tuesday, January 27th. Two research analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $615.86.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.